278 related articles for article (PubMed ID: 19072358)
1. Chemokine-directed immune cell infiltration in acute and chronic liver disease.
Karlmark KR; Wasmuth HE; Trautwein C; Tacke F
Expert Rev Gastroenterol Hepatol; 2008 Apr; 2(2):233-42. PubMed ID: 19072358
[TBL] [Abstract][Full Text] [Related]
2. The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection.
Zeremski M; Petrovic LM; Talal AH
J Viral Hepat; 2007 Oct; 14(10):675-87. PubMed ID: 17875002
[TBL] [Abstract][Full Text] [Related]
3. Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis.
Karlmark KR; Weiskirchen R; Zimmermann HW; Gassler N; Ginhoux F; Weber C; Merad M; Luedde T; Trautwein C; Tacke F
Hepatology; 2009 Jul; 50(1):261-74. PubMed ID: 19554540
[TBL] [Abstract][Full Text] [Related]
4. Chemokines in liver inflammation and fibrosis.
Wasmuth HE; Tacke F; Trautwein C
Semin Liver Dis; 2010 Aug; 30(3):215-25. PubMed ID: 20665374
[TBL] [Abstract][Full Text] [Related]
5. The fractalkine receptor CX₃CR1 protects against liver fibrosis by controlling differentiation and survival of infiltrating hepatic monocytes.
Karlmark KR; Zimmermann HW; Roderburg C; Gassler N; Wasmuth HE; Luedde T; Trautwein C; Tacke F
Hepatology; 2010 Nov; 52(5):1769-82. PubMed ID: 21038415
[TBL] [Abstract][Full Text] [Related]
6. Chemokines as immune mediators of liver diseases related to the metabolic syndrome.
Berres ML; Nellen A; Wasmuth HE
Dig Dis; 2010; 28(1):192-6. PubMed ID: 20460910
[TBL] [Abstract][Full Text] [Related]
7. Invading macrophages play a major role in the liver progenitor cell response to chronic liver injury.
Viebahn CS; Benseler V; Holz LE; Elsegood CL; Vo M; Bertolino P; Ganss R; Yeoh GC
J Hepatol; 2010 Sep; 53(3):500-7. PubMed ID: 20561705
[TBL] [Abstract][Full Text] [Related]
8. CC chemokine ligand-5 (CCL5/RANTES) and CC chemokine ligand-18 (CCL18/PARC) are specific markers of refractory unstable angina pectoris and are transiently raised during severe ischemic symptoms.
Kraaijeveld AO; de Jager SC; de Jager WJ; Prakken BJ; McColl SR; Haspels I; Putter H; van Berkel TJ; Nagelkerken L; Jukema JW; Biessen EA
Circulation; 2007 Oct; 116(17):1931-41. PubMed ID: 17909104
[TBL] [Abstract][Full Text] [Related]
9. [Pathogenesis of liver fibrosis: modulation of stellate cells by chemokines].
Wasmuth HE; Weiskirchen R
Z Gastroenterol; 2010 Jan; 48(1):38-45. PubMed ID: 20072995
[TBL] [Abstract][Full Text] [Related]
10. Augmented chemokine levels and chemokine receptor expression on immune cells during pulmonary tuberculosis.
Pokkali S; Das SD
Hum Immunol; 2009 Feb; 70(2):110-5. PubMed ID: 19100801
[TBL] [Abstract][Full Text] [Related]
11. Modification of chemokine pathways and immune cell infiltration as a novel therapeutic approach in liver inflammation and fibrosis.
Zimmermann HW; Tacke F
Inflamm Allergy Drug Targets; 2011 Dec; 10(6):509-36. PubMed ID: 22150762
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of Liver Injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions.
Jaeschke H
Am J Physiol Gastrointest Liver Physiol; 2006 Jun; 290(6):G1083-8. PubMed ID: 16687579
[TBL] [Abstract][Full Text] [Related]
13. Hepatic NKT cells: friend or foe?
Swain MG
Clin Sci (Lond); 2008 Apr; 114(7):457-66. PubMed ID: 18302533
[TBL] [Abstract][Full Text] [Related]
14. Determinants of CCL5-driven mononuclear cell migration across the blood-brain barrier. Implications for therapeutically modulating neuroinflammation.
Ubogu EE; Callahan MK; Tucky BH; Ransohoff RM
J Neuroimmunol; 2006 Oct; 179(1-2):132-44. PubMed ID: 16857269
[TBL] [Abstract][Full Text] [Related]
15. Innate immune response and hepatic inflammation.
Szabo G; Mandrekar P; Dolganiuc A
Semin Liver Dis; 2007 Nov; 27(4):339-50. PubMed ID: 17979071
[TBL] [Abstract][Full Text] [Related]
16. Targeting the chemokine network in renal inflammation.
Eis V; Vielhauer V; Anders HJ
Arch Immunol Ther Exp (Warsz); 2004; 52(3):164-72. PubMed ID: 15247883
[TBL] [Abstract][Full Text] [Related]
17. Chemokines in hepatitis C virus infection: pathogenesis, prognosis and therapeutics.
Wald O; Weiss ID; Galun E; Peled A
Cytokine; 2007 Jul; 39(1):50-62. PubMed ID: 17629707
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic potential of chemokine receptor antagonists for liver disease.
Sahin H; Berres ML; Wasmuth HE
Expert Rev Clin Pharmacol; 2011 Jul; 4(4):503-13. PubMed ID: 22114859
[TBL] [Abstract][Full Text] [Related]
19. Differential impact of the dual CCR2/CCR5 inhibitor cenicriviroc on migration of monocyte and lymphocyte subsets in acute liver injury.
Puengel T; Krenkel O; Kohlhepp M; Lefebvre E; Luedde T; Trautwein C; Tacke F
PLoS One; 2017; 12(9):e0184694. PubMed ID: 28910354
[TBL] [Abstract][Full Text] [Related]
20. Coagulation and fibrosis in chronic liver disease.
Calvaruso V; Maimone S; Gatt A; Tuddenham E; Thursz M; Pinzani M; Burroughs AK
Gut; 2008 Dec; 57(12):1722-7. PubMed ID: 19022928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
